Table 2.
Laboratory data of case 2
| Case 2 | Reference range, adult | 2 days after onset | 5 days after onset | 9 days after onset | 11 days after onset |
|---|---|---|---|---|---|
| Hematocrit (%) | 35.0–48.0 | 38.9 | 31.7 | 33.5 | 34.5 |
| Hemoglobin (g/dl) | 12.0–16.0 | 13.7 | 11.4 | 11.7 | 12.4 |
| White-cell count (/μL) | 4500–8500 | 1000 | 1050 | 5230 | 6240 |
| Platelet count (×104/μL) | 13.0–32.0 | 5.7 | 1.4 | 7.8 | 12.0 |
| Lymphocyte count (/μL) | 1000–4000 | 347 | |||
| Neutrophil count (/μL) | 1000–7500 | 535 | |||
| Aspartate aminotransferase (IU/L) | 13–33 | 144 | 218 | 2162 | 5897 |
| Alanine aminotransferase (IU/L) | 6–30 | 64 | 75 | 370 | 544 |
| Lactate dehydrogenase (IU/L) | 119–229 | 350 | 634 | 6765 | 10018 |
| Creatine phosphokinase (IU/L) | 45–163 | 424 | 1401 | 930 | 795 |
| Blood urea nitrogen (mg/dl) | 8.0–22.0 | 25 | 16.5 | 47.5 | 20.0 |
| Creatinine (mg/dl) | 0.4-0.7 | 0.88 | 0.74 | 3.20 | 1.19 |
| C-reactive protein (mg/dl) | <0.3 | 0.1 | 0.07 | 1.74 | 0.82 |
| Prothrombin time (%) | 70–120 | 73.0 | 84 | 66 | |
| Activated partial thromboplastin time (seconds) | 26.1–35.6 | 48.7 | 66.4 | 126.0 | |
| Fibrinogen (mg/dl) | 150–450 | 137 | 113 | <70 | |
| Antithrombin III (mg/dl) | 80–120 | 75.0 | 67 | 95 | 73 |
| Fibrin/fibrinogen degradation products (μg/ml) | <5.0 | 5.1 | 5.1 | 13.0 | 8.5 |
| D dimer (μg/ml) | <1.0 | 3.1 | 2.0 | 6.6 | 3.6 |